AVR - Anteris Technologies Global Corp. News

Anteris Technologies To Present First 30-Day Clinical And Hemodynamic Outcomes For Its Medium-Size D

The presentation will report 30-day outcomes in patients with severe aortic stenosis who received th

Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026

MINNEAPOLIS and BRISBANE, Australia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global C

Anteris Technologies secures German clearance to expand PARADIGM heart valve trial

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has secured full German regulatory clearance for

Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance

MINNEAPOLIS and BRISBANE, Australia, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global C

Cantor Fitzgerald Reiterates Overweight on Anteris Technologies Glb, Maintains $15 Price Target

Cantor Fitzgerald analyst Gabie Ingoglia reiterates Anteris Technologies Glb (NASDAQ:AVR) with a

Why Enovix Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Enovix jumps 6.8% after securing a 100,000-unit battery order from a multinational drone maker, with

Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Purchases $1,957,950.10 i

Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty L

Barclays Initiates Coverage On Anteris Technologies Glb with Equal-Weight Rating, Announces Price Ta

Barclays analyst Matt Miksic initiates coverage on Anteris Technologies Glb (NASDAQ:AVR) with a E

Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Buys $1,838,834.12 in Sto

Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty L

Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Buys $4,869,897.05 in Sto

Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty L

Anteris Technologies appoints Brent Moen as chief financial officer

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has appointed experienced financial executive Bre

BlackRock Inc. Acquires Shares of 5,771,213 Anteris Technologies Global Corp. $AVR

BlackRock Inc. bought a new position in shares of Anteris Technologies Global Corp. (NASDAQ: AVR) in

Anteris to Present at September Healthcare Investor Conferences

MINNEAPOLIS and BRISBANE, Australia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global C

ADAR1 Capital Management LLC Acquires New Position in Anteris Technologies Global Corp. $AVR

ADAR1 Capital Management LLC bought a new position in shares of Anteris Technologies Global Corp. (N

Cantor Fitzgerald Reiterates Overweight on Anteris Technologies Glb, Maintains $15 Price Target

Cantor Fitzgerald analyst Gabie Ingoglia reiterates Anteris Technologies Glb (NASDAQ:AVR) with a

Assenagon Asset Management S.A. Invests $6.35 Million in Anteris Technologies Global Corp. $AVR

Assenagon Asset Management S.A. bought a new stake in Anteris Technologies Global Corp. (NASDAQ: AVR

Reported Earlier, Anteris Technologies Glb Q2 EPS $(0.30) Misses $(0.21) Estimate, Sales $1.009M Mis

Anteris Technologies Glb (NASDAQ:AVR) reported quarterly losses of $(0.30) per share which missed th

Anteris Technologies Announces Results for the Second Quarter of 2026

MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global C

Anteris Technologies Global (NASDAQ:AVR) Major Shareholder L1 Capital Pty Ltd Sells 174,721 Shares

Anteris Technologies Global Corp. (NASDAQ: AVR - Get Free Report) major shareholder L1 Capital Pty L

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s

Porch Group, Micron And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

U.S. stock futures lower, Porch Group Inc (NASDAQ: PRCH) downgraded, pre-market trading sees several

Pennon returns to profit after water bill hikes

Pennon Group PLC (LSE:PNN, OTC:PEGRY) returned to the black in its latest financial as higher regula

Anteris Technologies Receives Full Regulatory Clearance From The French National Agency For Medicine

This authorization marks a significant milestone in the Company's clinical and regulatory strate

Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance

MINNEAPOLIS and BRISBANE, Australia, June 08, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global C

Anteris Technologies Global To Offer Up To $250M Of Common Stock Through TD Cowen

https://www.sec.gov/ix?doc=/Archives/edgar/data/0002011514/000114036126022633/ny20074564x2_8k.htm

Barclays Maintains Overweight on Anteris Technologies Glb, Raises Price Target to $18

Barclays analyst Matt Miksic maintains Anteris Technologies Glb (NASDAQ:AVR) with a Overweight an

Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors

MINNEAPOLIS and BRISBANE, Australia, May 13, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Co

Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has strengthened its board with the appointments

Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has reported strong operational progress for the

Anteris Announces Results for the First Quarter of 2026

MINNEAPOLIS and BRISBANE, Australia, May 12, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Co

Anteris Technologies Glb Q1 EPS $(0.28) Misses $(0.27) Estimate, Sales $494.000K Miss $766.667K Esti

Anteris Technologies Glb (NASDAQ:AVR) reported quarterly losses of $(0.28) per share which missed th

Anteris Technologies Receives U.S. Medicare Reimbursement Eligibility For Its Global Pivotal PARADIG

Eligible procedures performed at participating U.S. study sites are covered under the Transcatheter

Cantor Fitzgerald Reiterates Overweight on Anteris Technologies Glb, Maintains $15 Price Target

Cantor Fitzgerald analyst Gabie Ingoglia reiterates Anteris Technologies Glb (NASDAQ:AVR) with a

Cantor Fitzgerald Assumes Anteris Technologies Glb at Overweight, Announces Price Target of $15

Cantor Fitzgerald analyst Gabie Ingoglia assumes Anteris Technologies Glb (NASDAQ:AVR) with a Ove

Wells Fargo Initiates Coverage On Anteris Technologies Glb with Overweight Rating, Announces Price T

Wells Fargo analyst Larry Biegelsen initiates coverage on Anteris Technologies Glb (NASDAQ:AVR) w

Anteris Technologies Glb Q4 EPS $(0.75) Misses $(0.58) Estimate, Sales $310.000K Beat $200.000K Esti

Anteris Technologies Glb (NASDAQ:AVR) reported quarterly losses of $(0.75) per share which missed th

Anteris Technologies Global Completes $90M Investment From Medtronic

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structur

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?

Anteris Technologies shares surged over 52% in after-hours trading following the announcement of a $

Anteris Agrees To Sell Up To $90M In Shares To Medtronic Via Private Placement

Anteris Technologies Offers To Sell $200M Of Shares Through Proposed Underwritten Public Offering

Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR

12 Health Care Stocks Moving In Thursday's Intraday Session

Anteris Technologies Declines Renewal Of ADAPT Tissue Supply Agreement With 4C Medical, Contract To

On November 26, 2025, Anteris Technologies Global Corp. (the "Company") notified 4C Medical

Anteris Highlights 100% Technical Success In Last 50 DurAVR THV Implants And No Valve Related Mortal

30-day Results Highlights for 100 DurAVR THV PatientsDurAVR THV delivered a favorable hemodynamic pr

Anteris Receives FDA Approval To Initiate PARADIGM, Global IDE Clinical Trial Designed To Evaluate D

PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomi

12 Health Care Stocks Moving In Tuesday's After-Market Session

Anteris Technologies Enrolls First Patients In Global PARADIGM Pivotal Trial Of DurAVR Transcatheter

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR))) a global structu

Anteris Technologies To Present One-Year Clinical Outcomes With DurAVR Transcatheter Heart Valve, At

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR))), a global struct